Table 1

Summary of major complications following illicit drug use

Presentation

Substances implicated
Mechanism
Specific treatment

Respiratory compromise
Pneumothorax, haemothorax
Cocaine, cannabis
Barotrauma
Chest drainage

'Crack lung'
Cocaine
Interstitial and alveolar inflammatory infiltration
Systemic corticosteroid administration

Pulmonary oedema
Cocaine

Oxygen, diuretics, nitrates

Interstitial pneumonitis, BOOP
Cocaine

Ventilation where necessary
Chest pain/cardiovascular collapse
Pneumomediastinum, pneumopericardium
Cocaine, cannabis
Barotrauma
Drainage where necessary

Acute coronary syndrome
Cocaine
Alpha-adrenergic vasoconstriction, platelet aggregation
Sublingual nitrates, benzodiazepines

Arrhythmias and sudden death
Cocaine
Sodium channel blockade



Amphetamines
Sympathetic hyperstimulation



Cannabis


Confusion, convulsions, collapse, coma
With respiratory depression
Opioids, benzodiazepines, ethanol, GHB
Central sedation
Airway protection, ventilation

With hyponaturaemia
MDMA
Cerebral oedema (excess fluid consumption and ADH release)
Fluid restriction, hypertonic saline administration

Predominantly seizure activity
Cocaine, amphetamines
Central nervous system stimulation
Benzodiazepines


Opioids, GHB, benzodiazepines, ethanol
Withdrawal

Hyperthermia
With agitated and paranoid behaviour, collapse, and death
Cocaine (excited delirium)

Benzodiazepines, fluid resuscitation

In extremis without rigidity
MDMA (exertional hyperpyrexia)
Exertion, dehydration, arousal, environmental warming, alterations in skeletal muscle excitation-contraction coupling
Active cooling ± dantrolene

With rigidity
MDMA (serotonin syndrome)
Contraction of antagonistic muscle groups
Paralysis
Rhabdomyolysis
With coma
Opioids, benzodiazepines, ethanol, GHB
Pressure necrosis
Fluid administration, monitor for acute renal failure

With excessive muscle contraction
MDMA
Diffuse tissue disruption


Traumatic
Any
Impaired judgement, risk-taking behaviours


ADH, antidiuretic hormone; BOOP, bronchiolitis obliterans with organising pneumonia; GHB, gamma hydroxybutyrate; MDMA, 3,4-methylenedioxymethamphetamine

Devlin and Henry Critical Care 2008 12:202   doi:10.1186/cc6166